BioLine RX Ltd
Change company Symbol lookup
Select an option...
BLRX BioLine RX Ltd
BLPH Bellerophon Therapeutics Inc
BLNK Blink Charging Co
CTXS Citrix Systems Inc
AFHIF Atlas Financial Holdings Inc
RIOCF RioCan Real Estate Investment Trust
OMP Oasis Midstream Partners LP
GMED Globus Medical Inc
TSN Tyson Foods Inc
VOO Vanguard S&P 500 ETF
Go

Health Care : Biotechnology | Small Cap Value
Based in Israel

BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

Premarket

Last Trade: Delayed
$2.77

Change Since Close Change Since Close Postmarket extended hours change is based on the last price at the end of the regular hours period. Premarket extended hours change is based on the day's regular session close.: -0.18 (-6.10%)

Bid: --

Ask: --

B/A Size: --

Market Hours

Closing Price: $2.95

Day's Change: 0.00 (0.00%)

Bid close: --

Ask close: --

B/A Size: --

Day's High: --

Day's Low: --

Volume (Light) Volume: 82 10-day average volume: 1,283,936: 82

Unable to locate that news article. Back to news results

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Premarket

Change Since Close

Market Hours